Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| D001049 | Apnea NIH | 0.71 |
| D020181 | Sleep Apnea, Obstructive NIH | 0.45 |
| D012891 | Sleep Apnea, NIH | 0.45 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0002104 | Apnea HPO | 0.71 |
| HP:0002870 | Obstructive sleep apnea HPO | 0.45 |
| HP:0010535 | Sleep apnea HPO | 0.45 |
Navigate: Correlations HPO
There is one clinical trial.
The recent and unexpected occurrence of patients with the development of skin lesions on the hands and/ or feet has been described recently. As these cases occurred contemporaneously with the Coronavirus Disease 2019 (COVID-19) and as it was the most often occurrence of de novo frostbites, the question raised of whether there is a direct link between the occurrence of these lesions and infection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) the responsible for CoVID-19. Indeed, mechanisms of these lesions and the precise correlation with Sars-CoV-2 remains poorly understood. Therefore, this study aim to: 1. Determine the possible link with this virus, 2. Understand the mechanisms involved in the pathogenesis of these lesions.
Description: SARS-CoV-2 will be tested by Polymorphism Chain Reaction (PCR) (on the first day of consultation) and serological analysis ( at day 0 and day 15 after the first consultation)
Measure: Detection of SARS-CoV-2 by real-time PCR and serological test Time: assessing change between day 0 and day 15Description: Metagenomics analysis will be performed on nasopharyngeal, tonsil and perianal samples
Measure: Detection of SARS-CoV-2 by metagenomics analysis Time: Up to 2.5 months after inclusionDescription: Transcriptomic analysis will be conducted with RNA extracted from frozen skin samples
Measure: Detection of acrosyndrome by transcriptomic analysis of skin samples Time: Up to 2.5 months after inclusionAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports